Ask AI
ProCE Banner Activity

Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas

Slideset

Download these slides to learn about the current treatment landscape for poorly differentiated extrapulmonary neuroendocrine carcinomas and the role of emerging DLL3-targeted therapies for improving patient outcomes.

Released: September 30, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.